Clinical Trials Directory

Trials / Completed

CompletedNCT00791440

Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy

Psychosis in Schizophrenia: Mechanisms of Recovery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This study examines the impact of Cognitive-Behavior Therapy (CBT) on symptoms, physiological arousal, stressors, and the ways to deal with them in individuals with schizophrenia and related disorders. The primary aim of this study is to investigate the role cognitive coping strategies play in mediating the link between stress, physiological arousal, and psychotic symptoms in individuals with schizophrenia during recovery from psychosis.

Detailed description

This study examines the mechanisms of recovery from psychosis. Specifically, the study aims to evaluate the putative impact of enhancing cognitive coping strategies via Cognitive-Behavior Therapy for psychosis (CBTp) on subjective stress, autonomic regulation (physiological arousal), and psychotic symptoms in individuals with schizophrenia and related disorders. As part of the study, participants will be randomized to receive up to 26 weekly sessions of CBTp (over 30 weeks) or "treatment as usual". Research evaluations will completed at baseline, and after 10, 20 and 30 weeks. The study outcome measures include psychotic symptoms as measured by clinical interviews, along with ambulatory measures of autonomic regulation and self-reports of psychotic experiences during daily functioning using mobile devices (i.e., Palm computers).

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive-Behavior TherapyWeekly individual Cognitive-Behavior Therapy (CBT) to target hallucinations and delusions in addition to standard psychiatric treatment.
OTHERStandard Psychiatric TreatmentStandard psychiatric treatment.

Timeline

Start date
2008-11-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2008-11-14
Last updated
2012-12-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00791440. Inclusion in this directory is not an endorsement.